BR

Baban Ramrao Sanap

Director Director DIN 00921217
DIN 00921217 First appointment Dec 2000 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2000
Shareholding value •••• Premium profile

About Baban Ramrao Sanap

Data last updated:

Baban Ramrao Sanap was a Director at Adorn Chemicals Pvt Ltd (2000–2011) and Designated Partner at Surya Chemopharma Llp (2017–2020). The companies operate in Chemicals and Materials.

DIN 00921217
Primary Designation Director
Industry Chemicals and Materials
First Appointment 30 Dec 2000

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Adorn Chemicals Pvt Ltd U24110MH1993PTC071589
Director30 Dec 20001993₹2.19 Cr (FY 2025)Active
Designated Partner05 Jun 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adorn Chemicals Pvt Ltd
Surya Chemopharma Llp
Premium access

Shareholding and investment profile for Baban Ramrao Sanap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baban Ramrao Sanap

Baban Ramrao Sanap was first appointed on 30 Dec 2000 as Director at Adorn Chemicals Pvt Ltd. The most recent appointment on record is 05 Jun 2017 at Surya Chemopharma Llp.

Baban Ramrao Sanap held 2 earlier board appointments: Adorn Chemicals Pvt Ltd (Director, 30 Dec 2000 to 01 Mar 2011); Surya Chemopharma Llp (Designated Partner, 05 Jun 2017 to 06 Oct 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available